Erin Guest is a Clinical Research Medical Director on the Blinatumomab team at Amgen, where they have been since 2024. Previously, Erin served as Study Chair/Vice Chair for various Infant Acute Lymphoblastic Leukemia trials at the Children's Oncology Group from 2014 to 2024 and completed a Pediatric Residency at Children's Mercy Kansas City from 2004 to 2007. They hold a Bachelor of Science in Zoology/Animal Biology, summa cum laude, and a Doctor of Medicine with Distinction from the University of Oklahoma. Throughout their academic and professional journey, Erin has contributed significantly to pediatric hematology/oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices